Search Results

Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on Monday, November 8, 2021. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 8:50 a.m. Eastern Time.   The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through November 7, 2022.

Baxter Presents Critical Care Data at 34th Annual European Society of Intensive Care Medicine LIVES Congress

Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced the presentation of data from three critical care studies at the 34th Annual European Society of Intensive Care Medicine (ESICM) LIVES virtual congress taking place Oct. 3 – Oct. 6, 2021. 

Global Efforts Contribute to Sustainability in Healthcare

Around the world, our teams are taking creative approaches to help protect our planet.    

Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third-quarter 2021 financial results on Thursday, October 28, 2021 at 7:30 a.m. Central Time. To participate in this conference call please follow this link http://www.directeventreg.com/registration/event/3534264 to pre-register for the call and receive the call information.

Baxter Announces U.S. Approval and Launch of Ready-To-Use Cardiovascular Medicine Norepinephrine in Premix Formulation

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine). Norepinephrine is indicated to raise blood pressure in adult patients with severe, acute hypotension (low blood pressure).

Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally

Baxter International Inc. (NYSE:BAX), a leading global medical products company, and Hillrom (NYSE:HRC), a global medical technology leader, today announced that the companies have entered into a definitive agreement under which Baxter has agreed to acquire Hillrom for $156.00 per share in cash for a total equity value of approximately $10.5 billion and a total enterprise value of approximately $12.4 billion, including the assumption of debt. 

The Baxter International Foundation and UNICEF USA Announce Partnership to Improve Water Security in Colombia

The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF USA today announced a partnership to improve access to safe water in La Guajira, Colombia, one of the country’s most water-challenged regions.

Counselor for Progress

Corporate attorney talks about advancing racial justice at Baxter and lessons learned throughout her career   

Baxter Advances Enterprise Digital Transformation in Collaboration with AWS

Baxter International Inc. (NYSE:BAX), a global medical products company, is accelerating its companywide digital transformation across three strategic areas – developing new digital health solutions to personalize and improve patient care; creating seamless experiences for healthcare customers and patients; and modernizing technology capabilities and business processes to deliver data and insights to employees and customers. The company is working with Amazon Web Services, Inc.

Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc (NYSE:CRY) for up to $60.8 million, including $25 million paid upfront. The remainder will be paid out upon achievement of certain select milestones.